Gabitril (tiagabine hydrochloride) is a prescription medicine used with other medicines to treat partial seizures in adults and children age 12 and older.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
Suicidal Behavior and Ideation and Antiepileptic Drugs
Information for Healthcare Professionals: Suicidal Behavior and Ideation and Antiepileptic Drugs[ARCHIVED]
1/31/2008; updated 12/16/2008
Information for Healthcare Professionals: Tiagabine hydrochloride (marketed as Gabitril) - Seizures in Patients Without Epilepsy[ARCHIVED]
FDA Public Health Advisory: Seizures in Patients Without Epilepsy Being Treated With Gabitril (tiagabine), February 18, 2005[ARCHIVED]